681.82
-28.63
(-4.03%)
As of 8:29:47 AM CST. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 22 | 19 | 28 | 25 |
Avg. Estimate | 29.77B | 29.82B | 122.46B | 126.2B |
Low Estimate | 29.35B | 29.41B | 120.82B | 123.35B |
High Estimate | 30.13B | 30.42B | 123.65B | 129.62B |
Year Ago Sales | 30.06B | 29.69B | 123.73B | 122.46B |
Sales Growth (year/est) | -0.95% | 0.44% | -1.03% | 3.06% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CMCSA.MX | -- | -- | -- | -- |
S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
Maintains | Scotiabank: Sector Perform to Sector Perform | 4/8/2025 |
Maintains | UBS: Neutral to Neutral | 3/25/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 2/3/2025 |
Maintains | Rosenblatt: Neutral to Neutral | 2/3/2025 |
Downgrade | Scotiabank: Sector Outperform to Sector Perform | 2/3/2025 |
Maintains | Citigroup: Buy to Buy | 1/31/2025 |